Product image of Keytruda 100mg/4ml-EU (Pembrolizumab) 100mg/4ml Vials supplied by GNH India

Keytruda 100mg/4ml-EU

Active Ingredient:
Pembrolizumab
Form:
Vials
Brand:
Keytruda 100mg/4ml
Origin:
UK

Keytruda 100mg/4ml-EU (Pembrolizumab Vials) 100mg/4ml

Pembrolizumab, the active ingredient in Keytruda 100mg/4ml, is a PD-1 inhibitor presented as a 100mg/4ml vial for intravenous use. It is used in the treatment of various cancers, including melanoma, non-small cell lung cancer, and head and neck squamous cell carcinoma. GNH India supplies Keytruda 100mg/4ml as a licensed, GDP-compliant international pharmaceutical supplier serving oncology centres worldwide.

Keytruda 100mg/4ml is a cancer immunotherapy that works by enhancing the body's immune response against tumor cells. It is administered intravenously and is available in a 100mg/4ml vial formulation.

Strength

100mg/4ml

Pack Size

1s

Storage

2-8°

Manufacturer / TM Owner

Merck Sharp & Dohme Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Keytruda 100mg/4ml is a cancer immunotherapy that acts on the PD-1 pathway to help the immune system fight tumor cells. It is indicated for the treatment of several types of cancer, including:

  • Melanoma: Treatment of unresectable or metastatic melanoma.
  • Non-small cell lung cancer: Treatment of metastatic NSCLC with PD-L1 expression.
  • Head and neck squamous cell carcinoma: Treatment of recurrent or metastatic HNSCC with disease progression on or after platinum-containing chemotherapy.
  • Classical Hodgkin lymphoma: Treatment of relapsed or refractory cHL after autologous stem cell transplant or treatment with brentuximab vedotin.
  • Urothelial carcinoma: Treatment of locally advanced or metastatic urothelial carcinoma in patients not eligible for cisplatin-containing chemotherapy.
  • Gastric cancer: Treatment of recurrent or advanced gastric cancer with PD-L1 expression.

How It Works

  • Pembrolizumab is a monoclonal antibody that binds to the PD-1 receptor, blocking its interaction with PD-L1 and PD-L2. This blockade enhances T-cell mediated immune responses against tumor cells, allowing the immune system to recognize and attack cancer cells more effectively.

Side Effects

Keytruda 100mg/4ml may cause various side effects, which can be categorized as common or serious.

Common Side Effects

  • Fatigue: Feeling tired or weak.
  • Nausea: Feeling sick to the stomach.
  • Rash: Skin irritation or redness.
  • Itching: Skin discomfort or irritation.
  • Diarrhea: Loose or watery stools.
  • Decreased appetite: Reduced desire to eat.

Serious or Rare Side Effects

  • Immune-mediated pneumonitis: Inflammation of the lungs.
  • Immune-mediated colitis: Inflammation of the colon.
  • Immune-mediated hepatitis: Inflammation of the liver.
  • Immune-mediated nephritis: Inflammation of the kidneys.
  • Immune-mediated thyroid disorders: Thyroid dysfunction.
  • Infusion-related reactions: Allergic reactions during or after infusion.

Precautions & Warnings

Keytruda 100mg/4ml should be used with caution and under the supervision of a healthcare professional. Important precautions include:

  • Pregnancy: Avoid use during pregnancy due to potential risks to the fetus.
  • Breastfeeding: Avoid breastfeeding while using Keytruda 100mg/4ml.
  • Immunosuppression: Monitor for signs of immune-mediated adverse reactions.
  • Organ transplant: Avoid use in patients with organ transplants due to increased risk of rejection.
  • Allergic reactions: Monitor for signs of allergic reactions during and after infusion.
  • Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Keytruda 100mg/4ml may interact with other medications, which can be categorized as major or moderate.

Major Interactions (Avoid)

  • Other PD-1 inhibitors: Avoid concurrent use with other PD-1 inhibitors.
  • Immune-suppressing drugs: Avoid concurrent use with immune-suppressing drugs.
  • Live vaccines: Avoid concurrent use with live vaccines.

Moderate Interactions (Monitor Closely)

  • Corticosteroids: Monitor for signs of immune-mediated adverse reactions.
  • Antihypertensives: Monitor blood pressure regularly.
  • Antidiabetics: Monitor blood glucose levels regularly.

Frequently Asked Questions

Keytruda 100mg/4ml is used in the treatment of various types of cancer, including melanoma, non-small cell lung cancer, head and neck squamous cell carcinoma, classical Hodgkin lymphoma, urothelial carcinoma, and gastric cancer. It works by enhancing the body's immune response against tumor cells.

Pembrolizumab is a monoclonal antibody that binds to the PD-1 receptor, blocking its interaction with PD-L1 and PD-L2. This blockade enhances T-cell mediated immune responses against tumor cells, allowing the immune system to recognize and attack cancer cells more effectively.

The usual dose of Keytruda 100mg/4ml is determined by a healthcare professional based on the patient's condition and response to treatment. It is typically administered intravenously at a dose of 200 mg every 3 weeks or 400 mg every 6 weeks.

Keytruda 100mg/4ml should be avoided during pregnancy due to potential risks to the fetus. It is also recommended to avoid breastfeeding while using this medication. Always consult with a healthcare professional for personalized advice.

To order Keytruda 100mg/4ml from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will reply with pricing, availability, shipping, and the necessary import paperwork.

Keytruda 100mg/4ml is a cancer immunotherapy that works by enhancing the body's immune response against tumor cells. It is different from traditional chemotherapy, which directly kills cancer cells. Compared to other PD-1 inhibitors, Keytruda 100mg/4ml has shown efficacy in various types of cancer and is generally well-tolerated.

Keytruda 100mg/4ml should be stored at 2-8°C, protected from light, and not frozen or shaken. It should be handled by trained medical professionals and administered under the supervision of a healthcare provider. Always follow the manufacturer's guidelines for storage and handling.

Keytruda 100mg/4ml is administered intravenously by a healthcare professional. The infusion typically takes 30 minutes. The dose and frequency of administration are determined by a healthcare professional based on the patient's condition and response to treatment.

The most serious risks associated with Keytruda 100mg/4ml include immune-mediated adverse reactions such as pneumonitis, colitis, hepatitis, nephritis, and thyroid disorders. Patients should be monitored closely for signs of these reactions and report any symptoms to their healthcare provider immediately.

Keytruda 100mg/4ml should not be used by patients with a history of severe allergic reactions to Pembrolizumab or any of its components. It should also be avoided in patients with active autoimmune diseases or those who have received an organ transplant due to the increased risk of rejection.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pembrolizumab

Keytruda 100mg/4ml

Keytruda 100mg/4ml

100mg/4ml Vials
Keytruda

Keytruda

100mg/4ml Vials
Keytruda 100mg

Keytruda 100mg

100mg/4ml Vials
Keytruda 100mg/4ml

Keytruda 100mg/4ml

100mg/4ml

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT